Gx Acquisition Corp II (CELUW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Gx Acquisition Corp II (CELUW:NASDAQ), powered by AI.

Current Price
$0.01
Sector
Healthcare
What is the Gx Acquisition Corp II stock price forecast?

Gx Acquisition Corp II is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.

What is Gx Acquisition Corp II insider trading activity?

View the latest insider trading data for Gx Acquisition Corp II on Alpha Lenz.

What is Gx Acquisition Corp II's P/E ratio?

View Gx Acquisition Corp II's valuation metrics on Alpha Lenz.

Gx Acquisition Corp II

NASDAQ · CELUW
$0.01+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Gx Acquisition Corp II's future dividend policy...
Alpha Chat Insight

Gx Acquisition Corp II's ROE is 627.7%. Explore profitability and growth together.

Ask for details

Company Overview

Gx Acquisition Corp II is a special purpose acquisition company (SPAC) primarily designed to facilitate mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations with one or more businesses. Unlike traditional public companies, Gx Acquisition Corp II does not have operations of its own but instead raises capital through an initial public offering to acquire a privately held company, thereby bringing it public. This flexible structure is particularly appealing in industries with significant upcoming growth or innovation, where emerging companies may seek expedited entry into capital markets. Gx Acquisition Corp II’s process allows for the efficient deployment of funds to identify high-potential targets, possibly in technology, healthcare, or environmentally focused sectors. As part of the vast SPAC market, its strategic approach plays a critical role in offering private companies a streamlined path to public markets, thus influencing both market accessibility and investor opportunities within its selected focus industry.

CEODr. Robert Joseph Hariri M.D., Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees123

Company Statistics

FY 2025

Profile

N/AMarket Cap
$26.55MRevenue
0.00Shares Out
123Employees

Margins

24.39%Gross
-245.44%EBITDA
-230.92%Operating
-345.44%Pre-Tax
-345.45%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

13.88%Rev 3Yr
13.21%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-76.43%ROA
627.65%ROE
-70.80%ROIC

Financial Health

$6.17MCash & Cash Equivalents
$139.22MNet Debt
-381.98%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Gx Acquisition Corp II (ticker: CELUW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 123 employees.

The current price is $0.009 with a P/E ratio of -x and P/B of -x.

ROE is 627.65% and operating margin is -230.92%. Annual revenue is $27M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Gx Acquisition Corp II (CELUW) Stock Forecast 2026 $0.01 — Price, Financials & Analyst Targets | Alpha Lenz